This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Darba J, Restovic G.A budget impact model for determining the costs of introducing a new extrafine combination (beclomethasone/formoterol) for the treatment of moderate to severe persistent asthma in Spain. Value in Health 10: A398-A399 (plus poster) abstr. PAA3, No. 6, Nov-Dec 2007
Rights and permissions
About this article
Cite this article
Beclometasone/formoterol for asthma cost saving in Spain. Pharmacoecon. Outcomes News 543, 4 (2007). https://doi.org/10.2165/00151234-200705430-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705430-00008